1-4 of 4
Hiroji Uemura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

Tanya Dorff, Lisa G. Horvath, Karen Autio, Alice Bernard-Tessier, Matthew B. Rettig, Jean-Pascal Machiels, Mehmet A. Bilen, Martijn P. Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel S.W. Tan, Alvin Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M. Janát-Amsbury, Tobias Eggert, Ben Tran
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (8): 1488–1500.
https://doi.org/10.1158/1078-0432.CCR-23-2978
Published: 15 April 2024
View article titled, A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Open the PDF for A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer

Carlos Perez-Ruixo, Oliver Ackaert, Daniele Ouellet, Caly Chien, Hiroji Uemura, David Olmos, Paul Mainwaring, Ji Youl Lee, Margaret K. Yu, Juan Jose Perez-Ruixo, Matthew R. Smith, Eric J. Small
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (17): 4460–4467.
https://doi.org/10.1158/1078-0432.CCR-20-1041
Published: 01 September 2020
View article titled, Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
Open the PDF for Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer in another window
Journal Articles

Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate Cancer

Akihide Ryo, Hiroji Uemura, Hitoshi Ishiguro, Tatsuya Saitoh, Akira Yamaguchi, Kilian Perrem, Yoshinobu Kubota, Kun Ping Lu, Ichiro Aoki
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7523–7531.
https://doi.org/10.1158/1078-0432.CCR-05-0457
Published: 20 October 2005
View article titled, Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate Cancer
Open the PDF for Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate Cancer in another window
Journal Articles

Fluorescence in Situ Hybridization Evaluation of c- erbB-2 Gene Amplification and Chromosomal Anomalies in Bladder Cancer

Jun-ichi Ohta, Yasuhide Miyoshi, Hiroji Uemura, Kiyoshi Fujinami, Kunihisa Mikata, Masahiko Hosaka, Yoko Tokita, Yoshinobu Kubota
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2463–2467.
Published: 01 August 2001
View article titled, Fluorescence <em>in Situ</em> Hybridization Evaluation of c- <em>erbB-2</em> Gene Amplification and Chromosomal Anomalies in Bladder Cancer
Open the PDF for Fluorescence <em>in Situ</em> Hybridization Evaluation of c- <em>erbB-2</em> Gene Amplification and Chromosomal Anomalies in Bladder Cancer in another window